Delayed sentinel node biopsy for patients with DCIS undergoing mastectomy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates a novel approach to sentinel lymph node biopsy in patients diagnosed with ductal carcinoma in situ (DCIS) who are undergoing total mastectomy. Instead of removing the sentinel lymph node during the initial surgery, it is marked for identification and only excised later if invasive cancer is confirmed through histological examination. The primary endpoint is to evaluate the success rate of identifying the marked sentinel lymph node in cases where invasive cancer is detected. This method aims to minimize unnecessary procedures while ensuring accurate staging of cancer.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients aged 20 to 75 years old.
* Patients diagnosed with DCIS through histological examination.
* Patients undergoing mastectomy

Exclusion Criteria:

* In cases where the histopathological findings of the tissue examination indicate suspicious invasive lesions.
* In cases where imaging tests or physical examinations suggest possible lymph node metastasis.
* In patients who have previously undergone axillary lymph node surgery on the same side as the current procedure.
* Pregnant patients.

Where it's running

• Seoul National University Hospital
  Seoul, South Korea Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• HandX-assisted endoscopic nipple-sparing mastectomy (ATHENA I)

  This study tests whether a handheld robotic device called HandX can help surgeons safely perform a minimally invasive nipple-sparing mastectomy with immediate implant reconstruction for women having therapeutic or risk-reducing mastectomy.

  Recruiting Mediterraneo Hospital · Glyfada, Attica · NCT07292246

• Radiation therapy for early-stage breast cancer using a shorter treatment schedule

  This study is testing a shorter radiation treatment schedule for women 50 and older with early-stage breast cancer to see if it is safe and effective while reducing the number of visits needed.

  Recruiting Phase 2 UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina · NCT06902311

• Using nanoparticles for delayed lymph node biopsy in breast cancer patients

  This study is testing if using special nanoparticles can help breast cancer patients avoid unnecessary surgery by identifying important lymph nodes only when needed.

  Recruiting at 9 sites Phase 3 Uppsala University · Houston, Texas and 8 other locations · NCT04722692

• Shortened radiation therapy for women with breast cancer

  This study is testing if a shorter 3-day radiation treatment for breast cancer can work just as well and cause fewer side effects for women after surgery.

  Recruiting at 9 sites Phase 2 Memorial Sloan Kettering Cancer Center · Norwalk, Connecticut and 8 other locations · NCT04084730

• MRI-guided radiation therapy for early breast cancer

  This study is testing a new way to give radiation therapy for early breast cancer that uses MRI to protect healthy tissue and can be done in just one week.

  Recruiting Phase 2 University of Wisconsin, Madison · Madison, Wisconsin · NCT03936478

• Registry for patients with ductal carcinoma in situ (DCIS)

  This study is trying to see how the results of a specific test for ductal carcinoma in situ (DCIS) can change the treatment choices doctors make for patients with this condition.

  Recruiting at 30 sites PreludeDx · Scottsdale, Arizona and 29 other locations · NCT03448926

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.